Phase 3 Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Type 1 diabetes
Who may not be able to join:
- People who have other autoimmune diseases (conditions where the immune system attacks the body)
- People who have diabetes-related blood vessel or nerve complications, whether affecting small blood vessels (such as eye or kidney damage) or large blood vessels (such as heart or circulation problems)
- People who have other long-term (chronic) health conditions
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Rasha S Elmetwally, A. Prof, Assistant professor of Pediatrics, Faculty of Medicine, Ain Shams University
Phone: 20201092143033
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Insulin producing mesenchymal stem cells efficacy in insulin production in vitro; Insulin producing mesenchymal stem cells efficacy in insulin production in vitro; Insulin producing mesenchymal stem cells efficacy in insulin production in vivo
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.